본문 바로가기

전체 글

(819)
Chronic Inflammatory Demyelinating Polyneuropathy Market Analysis, Epidemiology and Market Forecast to 2030 Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare neurological disorder characterized by progressive weakness and impaired sensory function in the legs and arms mainly caused by damage to the myelin sheath (the fatty covering that wraps around and protects nerve fibres) of the peripheral nerves. Chronic Inflammatory Demyelinating Polyneuropathy Market Analysis The Chronic Inflam..
Tuberous Sclerosis Complex Market Analysis, Epidemiology and Market Forecast to 2030 Tuberous Sclerosis Complex (TSC) is a genetic disorder characterized by the growth of numerous non-cancerous (benign) tumors in many parts of the body. These tumors can occur in the skin, brain, kidneys, and other organs, in some cases leading to significant health problems. It was firstly described in the 1880s by French neurologist Désiré-Magloire Bourneville. Tuberous Sclerosis Complex Market..
Genital Herpes Market Analysis, Epidemiology and Market Forecast 2030 Genital Herpes (GH), is a common sexually transmitted disease caused due to two viruses namely: herpes simplex virus 1 (HSV1) and herpes simplex virus 2 (HSV2) characterized by lifelong infection and periodic reactivation with no cure. Viruses penetrate the body through mucous membranes which line the openings of nose, mouth and genitalia.HSV1, HSV2 are found in body fluids of infected person. G..
Eosinophilic Esophagitis Market Analysis, Epidemiology and Market Forecast 2030 Eosinophilic Esophagitis (EoE), often referred to as “asthma of the esophagus”, is a chronic allergic/immune condition, which tends to reflect many similar clinical and pathophysiologic characteristics as with asthma. It is characterized by the inflammation of esophagus, and hence, termed as an atopic inflammatory disease of the esophagus. Eosinophilic Esophagitis Market DelveInsight's "Eosinoph..
CAR T-Cell Therapy for Multiple Myeloma Multiple myeloma is a rare type of cancer that develops in plasma cells. A cure for Multiple Myeloma currently doesn’t exist. However, significant research is making progressive leaps toward a treatment that eliminates cancer entirely. As per Delveinsight's estimate, Market Size of CAR T-Cell Therapy for Multiple Myeloma in the 6MM is expected to be USD 3,766.4 Million in 2030. Owing to the laun..
Artificial Intelligence and Novel Coronavirus (COVID-19) crisis The novel coronavirus within a span of five-month has infected around 1 million people, resulting in deaths of 50,000 people in over 180 countries around the world till date. To deal with the spread and diagnosis of coronavirus, tech-companies and governments around the #world are working in collaboration to use AI-based solutions to contain and mitigate its further transmission. Some of the art..
CAR-T Cell Therapy Market In Acute Lymphoblastic Leukemia (ALL) Acute lymphocytic leukemia (ALL) is a tumor that afflicts bone marrow and hampers the production of healthy White blood cells. ALL is acute cancer denoting its rapid progression, if not treated can be fatal within a few months. DelveInsight estimates by 2030, the Car-T cell therapy market in Acute lymphoblastic leukaemia would approximate to USD 1,315.7 million in the 6MM (U.S. and EU5 including..
Warm Autoimmune Hemolytic Anemia Market Forecast and Pipeline Analysis In 2017, as per the estimates by DelveInsight, Warm Autoimmune Haemolytic Anemia had affected 82,045 people approximately in the 7MM. WAIHA affects around 1 in 35,000 people in North America. With a population of about 57 crores, WAIHA is a cause of distress to many living in that continent only, let alone worldwide. As of now, there exists no FDA-approved therapy in the Warm autoimmune hemolyti..